Nathalie Bougenies
Nathalie practices corporate law, intellectual property, and cannabis law, focusing on the regulatory framework of hemp-derived CBD products. She enjoys building a deep understanding of our clients’ businesses, industries, and long-term visions, and leverages her broad expertise and international background to help our overseas companies with their foreign direct investment into the United States and to help American companies with their overseas legal needs.
Posts
FDA Warns Consumers Of Risks Associated With Delta-8 THC Products
The Food and Drug Administration released its first statement via a consumer update regarding Delta-8 THC.
FDA Continues To Show It Is Not Interested In Regulating Hemp-Derived Products
The FDA seems to be holding hemp-derived CBD companies to a higher standard for new dietary ingredients.
Colorado’s New Hemp Rules Suggest Wave Of Comprehensive State Regulations
State regulators are keeping up with the demands of this evolving market.
Hemp Industries Association Urges Regulation, Not Prohibition, Of Delta-8 THC
It is true that most Delta-8 THC sold in the U.S. is largely unregulated, readily accessible to minors and highly coveted for its psychoactive effects.
Can You Legally Smoke Weed In DC? It’s Complicated
The commercial sale of recreational cannabis products is expressly prohibited in the District. But cannabis laws are not so black and white.
Will New York’s Cannabis Law Create Sweeping Changes For Its Hemp Industry?
Gov. Cuomo signed into law the “Marijuana Regulation and Taxation Act“ which includes provisions that may change how the state will regulate its hemp industry.
